South Carolina's HIV/AIDS problem is an enormous one

NewsGuard 100/100 Score

South Carolina's HIV/AIDS "problem is an enormous one," and state lawmakers "need to review the programs that fund HIV treatment" in the state, a Columbia State editorial says. South Carolina's HIV prevalence ranks 10th nationwide, and 74% of newly diagnosed HIV cases are among black residents, the editorial says.

In addition, HIV/AIDS advocates have said that the state budget has allocated $500,000 for the state's AIDS Drug Assistance Program, which provides antiretroviral drugs to HIV-positive residents, whereas North Carolina allocated $12 million, according to the editorial. South Carolina's ADAP has 144 people on the waiting list, the editorial adds.

"In our prosperous society, no one should have to wait for the medicines that control the damage that HIV does to the immune system," the editorial says, adding, "Forcing people to wait is more than cruel; it puts off a chance to limit the disease's damage. ... [I]f a lack of state dollars is causing people to wait for medications, that must be fixed" (Columbia State, 8/26).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New report on HIV drug resistance: Challenges and recommendations